Global Interventional Oncology - Forecast to 2026 - ResearchAndMarkets.com

The "Interventional Oncology Global Market - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Interventional Oncology (I.O.) is a rapidly growing field in cancer care that uses minimally invasive procedures performed under image guidance to diagnose and treat patients with liver, kidney, lung, and other cancers. Rather than removing tumors through open surgical procedures, these image-guided procedures can be performed in place of or in combination with other cancer treatments to provide truly comprehensive care. The advantage of these methods is that I.O. has much less effect on the body compared to conventional procedures.

An estimated by the publisher, the interventional oncology global market is expected to grow at a high single digit CAGR from 2019 to 2026 to reach $2,119.4 million by 2026. Some of the factors driving the market are increasing prevalence of cancer cases, growing adoption of minimally invasive procedures, increasing geriatric population, technological advancements in the field of interventional oncology, and expansion in the emerging markets.

The interventional oncology global market is a consolidated market with top 5 players occupying major share of the market hence all the existing players in this market are involved in developing new and advanced therapeutics to maintain their market shares.

Key Topics Covered:

1 Executive Summary

2 Introduction

2.1 Key Takeaways

2.2 Scope of the Report

2.3 Report Description

2.4 Markets Covered

2.5 Stakeholders

2.6 Research Methodology

3 Market Analysis

3.1 Introduction

3.2 Market Segmentation

3.3 Factors Influencing Market

3.3.1 Drivers and Opportunities

3.3.1.1 Increasing Prevalence of Cancer Cases

3.3.1.2 Growing Adoption of Minimally Invasive Procedures

3.3.1.3 Increasing Geriatric Population

3.3.1.4 Technological Advancements in the Field of Interventional Oncology

3.3.1.5 Expansion in the Emerging Markets

3.3.2 Restraints and Threats

3.3.2.1 Side Effects and Risks Associated with the Use

3.3.2.2 Lack of Awareness and Understanding About Interventional Oncology Importance

3.3.2.3 Lack of Trained Professionals

3.3.2.4 Availability of Alternative Treatments

3.3.2.5 Stringent Regulatory Guidelines

3.4 Regulatory Affairs

3.4.1 International Organization For Standardization

3.4.1.1 Iso 9001: 2015 Quality Management System

3.4.1.2 Iso 13485 Medical Devices

3.4.1.3 Iso 10993 Biological Evaluation of Medical Devices

3.4.1.4 Iso 14971 Risk Management of Medical Devices

3.4.1.5 Iso 12807:2018 Safe Transport of Radioactive Materials-Leakage Testing On Packages

3.4.1.6 Iec 60601-1 Medical Electrical Equipment Standard

3.4.1.7 Iec 60601-1-2 Electromagnetic Compatibility (Emc) For Medical Devices

3.4.2 U.S.

3.4.3 Canada

3.4.4 Europe

3.4.5 Japan

3.4.6 China

3.4.7 India

3.5 Clinical Trials Data

3.6 Porter's Five Force Analysis

3.7 Supply Chain Analysis

3.8 Reimbursement Scenario

3.9 Regulatory Approved Interventional Oncology Products by Company

3.10 Funding Scenario

3.11 Market Share Analysis by Major Players

3.12 Interventional Oncology Number of Units by Region

3.13 Interventional Oncology Procedure Volume by Product Type

3.14 Market Penetration of Interventional Oncology by Application

3.15 Interventional Oncology Company Comparison Table by Revenue, Product and Application

4 Interventional Oncology Global Market, by Product

4.1 Introduction

4.2 Ablation

4.3 Embolization

5 Interventional Oncology Global Market, by Application

5.1 Introduction

5.1.1 Liver Cancer

5.1.2 Kidney Cancer

5.1.3 Lung Cancer

5.1.4 Brain and Spine Cancer

5.1.5 Prostate Cancer

5.1.6 Uterine Fibroids

5.1.7 Other Applications

6 Interventional Oncology Global Market, by End-Users

6.1 Introduction

6.1.1 Hospitals

6.1.2 Ambulatory Surgical Centers (ASC's)

6.1.3 Academics and Research Institutes

7 Regional Analysis

7.1 Introduction

7.2 North America

7.3 Europe

7.4 APAC

7.5 RoW

8 Competitive Landscape

8.1 Introduction

8.2 Product Approval

8.3 Acquisition and Partnership

8.4 New Product Launch

8.5 Others

9 Major Companies

Companies Mentioned

  • ABK Biomedical Inc.
  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • Clinical Laserthermia Systems
  • Delcath Systems, Inc
  • Erbe Elktromedizin GmbH
  • Guerbet
  • IceCure Medical
  • IMBiotechnologies
  • Johnson & Johnson
  • Medtronic Plc
  • MedWaves Medical
  • Merit Medical System
  • Misonix
  • Monteris Medical Inc
  • Profound Medical Corp.
  • Royal Phillips
  • Sanarus Medical
  • Sirtex Medical
  • SonaCare Medical LLC
  • Terumo Corporation
  • Trod Medical
  • Varian Medical System

For more information about this report visit https://www.researchandmarkets.com/r/5lb733

View source version on businesswire.com: https://www.businesswire.com/news/home/20200326005399/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900